Cure My Disease

Don't miss your cure!

 Log in / Sign up

Exploring the effectiveness of a multimodal artificial intelligence application on bowel preparation outcomes for colonoscopy

NCT ID NCT07812155

NEW Sponsor: Chiayi Christian Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 10, 2026 · Last updated Sep 10, 2026

Summary

This randomized controlled trial aims to evaluate the effectiveness of a multimodal artificial intelligence (AI)-assisted smartphone application in improving bowel preparation outcomes among hospitalized adults undergoing colonoscopy. A total of 140 participants will be randomly assigned in a 1:1 ratio to either an experimental group or a control group. The control group will receive conventional written and verbal nursing education, while the experimental group will receive the same standard education plus a multimodal AI-assisted application delivered through the LINE platform. The application provides structured bowel preparation education, interactive AI-based question-and-answer support, dietary image recognition, stool image analysis, and individualized feedback. Study outcomes will include bowel preparation knowledge, satisfaction with nursing education, and bowel cleansing quality assessed using the Aronchick Scale.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 140 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Hospitalized adults scheduled to undergo colonoscopy. Age 20 years or older. Able to read. Conscious and able to communicate in Mandarin or Taiwanese. Own a smartphone and have basic ability to use the LINE application. Exclusion Criteria: Patients receiving hemodialysis or peritoneal dialysis. Patients unable to take bowel cleansing medication orally. Patients unable to consume a large volume of fluids. Patients with intestinal stenosis, bowel obstruction, or obstructing intestinal tumors. Patients with severe active gastrointestinal bleeding (\>1500 mL/day).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bowel preparation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bowel preparation Colonoscopy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Chiayi Christian Hospital

    RECRUITING

    Chiayi City, Taiwan, 60002, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.